| | Normoxia | Hyp + PBS | Hyp + CSF-1 |
---|
P5
|
% Tissue
| 34.92 ± 1.83 | 28.31 ± 1.83 | 32.15 ± 1.74 |
|
% Airspace
| 65.08 ± 1.83 | 71.69 ± 1.83 | 67.85 ± 1.74 |
|
MLI
| 113.00 ± 3.22 | 121.70 ± 7.97 | 116.40 ± 3.45 |
P35
|
% Tissue
| 36.97 ± 1.29 | 38.48 ± 2.01 | 36.92 ± 0.88 |
|
% Airspace
| 63.03 ± 1.29 | 61.52 ± 2.01 | 63.08 ± 0.88 |
|
MLI
| 64.99 ± 1.78 | 72.66 ± 1.22 a* | 75.27 ± 2.79 b** |
- Morphometric estimation of percentage tissue, percentage airspace and mean linear intercept at P5 at the cessation of treatment (n = 4-5/group), and at P35 (n = 6-7/group). Data were analysed by one-way ANOVA and Tukey’s post-hoc test. `a’ represents significant difference between Norm and Hyp + PBS, `b’ represents significant difference between Norm and Hyp + CSF-1. *p < 0.05, **p < 0.01.